Retatrutide is an experimental medicine, a combined peptide therapy. It acts as a triple agonist on GLP-1, GIP, and Glucagon receptors .

Mechanism of Action:
* Acts on multiple receptors for appetite and metabolism control .
* Reduces appetite .
* Improves glycemic control .
* Promotes significant weight loss .
* Potential to improve insulin sensitivity .

Potential Benefits:
* Important reduction in body weight .
* Improvement in metabolic parameters .
* Control of glycemia and insulin .

Use:
* Still in clinical trial phase (not commercially available) .
* Administered via subcutaneous injection, usually once daily.